Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Australasian Leukaemia and Lymphoma Group
Merck Sharp & Dohme LLC
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center